GastroAGI Logo
OverviewBlogsAbout
Trending TopicsDaily BriefConference
Topics/Gallbladder and Pancreas/GCAL Score Helps Triage EUS in Unexplained Bile Duct Dilatation | Indian Journal of Gastroenterology
17

GCAL Score Helps Triage EUS in Unexplained Bile Duct Dilatation | Indian Journal of Gastroenterology

Clinical knowledge base written and curated by GastroAGI Team from primary medical literatureLast updated April 1, 2026

Introduction

Unexplained common bile duct (CBD) dilatation is a frequent and often challenging clinical finding in gastroenterology practice. Although cross-sectional imaging may fail to identify a cause, endoscopic ultrasound (EUS) can detect clinically significant biliary and periampullary pathology that may require intervention. The challenge lies in identifying which patients are most likely to benefit from EUS while avoiding unnecessary procedures in low-risk individuals.

Problem Statement

Not all patients with isolated CBD dilatation harbor clinically meaningful pathology, yet routine EUS for all such patients is resource-intensive and may not be justified. A practical and validated clinical tool is needed to identify patients with a high likelihood of actionable findings and better guide EUS utilization in this increasingly common diagnostic scenario.

Summary

This study presents the development and prospective validation of the GCAL score, a practical risk stratification tool designed to identify patients with unexplained CBD dilatation who are most likely to benefit from EUS. The score incorporates five readily available clinical variables—gallbladder status, CBD diameter, age and liver function abnormalities—to predict the likelihood of actionable findings requiring endoscopic or surgical intervention. In both derivation and validation cohorts, EUS identified actionable pathology in approximately half of patients, underscoring its diagnostic value in this setting. The GCAL score demonstrated strong predictive performance and reliably distinguished patients at higher risk of clinically significant findings from those less likely to benefit from further invasive evaluation. Importantly, the model performed particularly well in prospective validation, supporting its clinical applicability in routine practice. These findings provide a simple and clinically relevant framework for triaging EUS in patients with unexplained bile duct dilatation and may help optimize procedural selection, improve diagnostic efficiency and reduce unnecessary investigations.

Related Q&A

18

SPINK1 p.Asn34Ser: Gastroenterology | May 2026

Introduction The SPINK1 gene encodes the pancreatic secretory trypsin inhibitor, a key protective molecule that prevents premature trypsin activation within the pancreas. Dysfunction of this pathway is central...

19

Rome V Gallbladder and Sphincter of Oddi Disorders: Gastroenterology | May 2026

The Rome V Gallbladder and Sphincter of Oddi Disorders chapter substantially modernizes this field by moving away from historically overused functional labels and procedure-driven diagnosis toward a more...

20

Optimal Timing of Endoscopic Necrosectomy After Catheter Drainage: Gastroenterology/ May 2026

Introduction Management of necrotising pancreatitis has evolved toward a minimally invasive, step-up approach, where initial catheter drainage—either percutaneous or endoscopic—is followed by endoscopic necrosectomy only when required. A...

21

Chronic Pancreatitis- From Inflammation to Fibrosis: Gastroenterology | May 2026

Article Type: Review — Basic and Clinical Gastroenterology & Hepatology Introduction and Summary Chronic pancreatitis is a progressive fibro-inflammatory disease characterised by recurrent or persistent abdominal pain, exocrine...

22

SPINK1 p.Asn34Ser: Gastroenterology | May 2026

Introduction The SPINK1 gene encodes the pancreatic secretory trypsin inhibitor, a key protective molecule that prevents premature trypsin activation within the pancreas. Dysfunction of this pathway is central...

23

Gallbladder Polyps: Are We Still Over-Operating Despite New Guidelines? UEG Journal | July 2026

Introduction Gallbladder polyps are commonly detected incidentally, with a prevalence of up to 7% in adults. The vast majority are benign, while only a small fraction represent adenomas...

GastroAGI Logo

We are pioneers in clinical intelligence, dedicated to helping gastroenterologists harness the power of artificial intelligence to drive precision, efficiency, and patient growth.

For You

For StudentsFor CliniciansFor ResearchersSoonFor Patients

Core Tools

MELD-Na ScoreChild-PughFIB-4 IndexGlasgow-BlatchfordBISAP Score

Explore

OverviewAboutCalculators
Trending Topics
Conference Briefings
Blog Insights
©GastroAGI 2026
Privacy PolicyTerms of UseMedical Disclaimer